Epicflow

DECEMBER 20, 2024

The pharmaceutical landscape is constantly evolving, driven by digital innovation s and the need to respond to current healthcare challenges. What should pharmaceutical companies expect of the upcoming year? Lets dive deeper into the key trend s facing the pharmaceutical industry in 2025.

Pharmaceuticals 52

Pharmaceuticals Trends Industry Healthcare 52

Clarity Consultants

JANUARY 25, 2017

Our story begins in 2013, when a major global pharmaceutical firm launched a technology transfer project from one of its US factories to a new factory being constructed in Europe.

Methodologies 49

Methodologies Pharmaceuticals Training Training 49

Epicflow

JANUARY 31, 2023

Becoming a competent and sought-after project manager is impossible without constant professional development. The essays are based on Scott Berkun’s work experience as a project manager at Microsoft, which however doesn’t mean that his guidelines will be useful for software development projects only.

Management 11

Management Handbook Case Study Case Studies 11

Harvard Business

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development.

Data 28

Data Pharmaceuticals Biotechnology Methodologies 28

Management Consulted

OCTOBER 3, 2012

Getting married and later becoming a father gave me a sense of responsibility and higher career aspirations – now I regard my career development as important like never before. “I led teams in development of an entirely new business unit inside a Fortune 50 company. This next one was submitted by the father of a premium client.

Consulting 204

Consulting Case Interview Interviews Engineering 204

Do It! Marketing

JUNE 12, 2024

The development of vaccines and antiviral drugs is ongoing, yet none have reached the point of widespread availability. The prospect of repurposing a well-known compound such as Sutaprim provides a promising avenue for expanding our antiviral arsenal without the protracted timeline of developing new drugs from scratch.

Study 52

Study Biotechnology Research Pharmaceuticals 52

Harvard Business

MAY 10, 2016

The rationale for this approach is highlighted when you compare, for example, the different approaches to M&A employed by a number of legacy pharmaceutical companies and by some relatively newer players in the biotechnology industry. For example, Gilead grew from a tiny startup developing H.I.V.

Company 28

Company Strategy Strategy& Strategy 28